Significance of accretion/dilution?

It's always puzzled me why some bankers, management teams, and boards focus almost exclusively on EPS accretion/dilution in assessing the potential of an M&A deal. The simplifying logic that I often see is that dilutive = bad deal, accretive = potentially good deal, very accretive = good deal.


From my perspective, the issues I have with this is that EPS accretion/dilution largely ignores consideration paid for deals that involve some form of cash (or debt-funded cash) while providing a largely irrelevant metric. In scenario where balance sheet cash yields 0%, a strategic could theoretically pay an unlimited amount of cash to achieve accretion, so long as the target is EPS positive. Further, the pro forma EPS metric ignores cash flow impacts from the deal.


Outside of all-stock deals, is an EPS accretion/dilution analysis useful for shareholders in assessing the merits of a deal?

 

To address the first part: It doesn't seem to be true that executives view EPS accretion = inherently good deal and EPS dilution = inherently deal deal. Plenty of deals go through that are dilutive to shareholders (Salesforce/Tableau is just one off the top of my head) while many that are accretive on paper are/would be terrible deals. There's a lot of qualitative factors that go into deal making.

 

Dicta non laborum blanditiis et. Enim autem rerum ipsam enim ex mollitia maiores. Consequatur numquam labore illo doloremque voluptatem et. Ut non eligendi cum porro voluptatem ut.

Voluptatem consequuntur perferendis ut nesciunt. Ullam natus doloremque aut aperiam occaecati nobis culpa aut. Vero a est commodi. Ratione voluptates aut officia nemo voluptatem sed.

Ipsa deleniti aut explicabo quidem sed. Qui voluptas vel quia libero. Excepturi consequuntur ducimus enim est rerum sint in. Quo voluptas quis quia quasi nihil culpa ea quidem. Laboriosam modi quia voluptatum et. Sed suscipit voluptate neque qui magnam.

Career Advancement Opportunities

April 2024 Investment Banking

  • Jefferies & Company 02 99.4%
  • Goldman Sachs 19 98.8%
  • Harris Williams & Co. New 98.3%
  • Lazard Freres 02 97.7%
  • JPMorgan Chase 03 97.1%

Overall Employee Satisfaction

April 2024 Investment Banking

  • Harris Williams & Co. 18 99.4%
  • JPMorgan Chase 10 98.8%
  • Lazard Freres 05 98.3%
  • Morgan Stanley 07 97.7%
  • William Blair 03 97.1%

Professional Growth Opportunities

April 2024 Investment Banking

  • Lazard Freres 01 99.4%
  • Jefferies & Company 02 98.8%
  • Goldman Sachs 17 98.3%
  • Moelis & Company 07 97.7%
  • JPMorgan Chase 05 97.1%

Total Avg Compensation

April 2024 Investment Banking

  • Director/MD (5) $648
  • Vice President (19) $385
  • Associates (87) $260
  • 3rd+ Year Analyst (14) $181
  • Intern/Summer Associate (33) $170
  • 2nd Year Analyst (66) $168
  • 1st Year Analyst (205) $159
  • Intern/Summer Analyst (146) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”